For MMP9 and PGAM1, both normal (OK113) and cancer (SqCC/Y1) exosomes triggered dose-dependent upregulation of MMP9 and PGAM1, but cancer exosomes were significantly more potent than normal exosomes (Fig. 7a). Here, MMP9 is linked to cancer.